Gilder Gagnon Howe & CO LLC Voyager Therapeutics, Inc. Transaction History

Gilder Gagnon Howe & CO LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	SELL	$6.94 - $13.99 $15,448 - $31,141	-2,226 Reduced 2.3%	94,551 $1.08 Million
Q1 2023 May 15, 2023	BUY	$6.0 - $10.78 $164,778 - $296,051	27,463 Added 39.62%	96,777 $746,000
Q4 2022 Feb 14, 2023	SELL	$4.94 - $6.61 $26,147 - $34,986	-5,293 Reduced 7.09%	69,314 $422,000
Q3 2022 Nov 14, 2022	BUY	$5.57 - $7.47 $96,884 - $129,933	17,394 Added 30.4%	74,607 $442,000
Q2 2022 Aug 15, 2022	BUY	$4.82 - $10.09 $275,766 - $577,279	57,213 New	57,213 $338,000
Q1 2018 Apr 30, 2018	SELL	$16.16 - $31.31 $14,172 - $27,458	-877 Closed	0 $0
Q4 2017 Jan 31, 2018	SELL	$12.26 - $25.88 $16,428 - $34,679	-1,340 Reduced 60.44%	877 $15,000
Q3 2017 Nov 06, 2017	BUY	$8.37 - $20.59 $18,556 - $45,648	2,217	2,217 $46,000

128

36.7M

48K

36.2K

Ticker VYGR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 38,647,600
Market Cap $226M
Description
Voyager Therapeutics, Inc., a gene therapy company, focuses on the development of treatments and next-generation platform technologies. The company's lead clinical candidate is the VY-AADC, which is in open-label Phase 1 clinical trial for the treatment of Parkinson's disease. Its preclinical programs comprise VY-SOD102 for the treatment of amyo...

Get notified when there are updates to the investment portfolio of Gilder Gagnon Howe & CO LLC, based on Form 13F filings with the SEC.

Stay updated on Gilder Gagnon Howe & CO LLC with notifications on news.